Canopy Growth Corp - Asset Resilience Ratio

Latest as of December 2025: 15.73%

Canopy Growth Corp (WEED) has an Asset Resilience Ratio of 15.73% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CA$174.03 Million
≈ $125.89 Million USD Cash + Short-term Investments

Total Assets

CA$1.11 Billion
≈ $800.20 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Canopy Growth Corp's Asset Resilience Ratio has changed over time. Check Canopy Growth Corp PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Canopy Growth Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see WEED market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CA$169.00 Million 15.28%
Short-term Investments CA$5.03 Million 0.46%
Total Liquid Assets CA$174.03 Million 15.73%

Asset Resilience Insights

  • Good Liquidity Position: Canopy Growth Corp maintains a healthy 15.73% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Canopy Growth Corp Industry Peers by Asset Resilience Ratio

Compare Canopy Growth Corp's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131
Drug Manufacturers - Specialty & Generic 1.37%
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
Drug Manufacturers - Specialty & Generic 24.59%
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099
Drug Manufacturers - Specialty & Generic 0.20%
Celltrion Pharm Inc
KQ:068760
Drug Manufacturers - Specialty & Generic 12.49%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Heilongjiang ZBD Pharmaceutical Co Ltd
SHG:603567
Drug Manufacturers - Specialty & Generic 0.00%
Zhejiang Anglikang Pharmaceutical Co Ltd Class A
SHE:002940
Drug Manufacturers - Specialty & Generic 9.11%

Annual Asset Resilience Ratio for Canopy Growth Corp (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Canopy Growth Corp.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 1.94% CA$17.79 Million
≈ $12.87 Million
CA$917.70 Million
≈ $663.85 Million
-5.01pp
2024-03-31 6.95% CA$90.40 Million
≈ $65.39 Million
CA$1.30 Billion
≈ $940.64 Million
-6.17pp
2023-03-31 13.13% CA$320.14 Million
≈ $231.59 Million
CA$2.44 Billion
≈ $1.76 Billion
-2.92pp
2022-03-31 16.05% CA$900.97 Million
≈ $651.75 Million
CA$5.62 Billion
≈ $4.06 Billion
-11.25pp
2021-03-31 27.30% CA$1.86 Billion
≈ $1.35 Billion
CA$6.82 Billion
≈ $4.94 Billion
+8.39pp
2020-03-31 18.91% CA$1.30 Billion
≈ $938.17 Million
CA$6.86 Billion
≈ $4.96 Billion
-13.29pp
2019-03-31 32.20% CA$2.81 Billion
≈ $2.03 Billion
CA$8.73 Billion
≈ $6.32 Billion
+32.15pp
2018-03-31 0.05% CA$664.00K
≈ $480.33K
CA$1.44 Billion
≈ $1.04 Billion
-12.51pp
2017-03-31 12.56% CA$85.10 Million
≈ $61.56 Million
CA$677.61 Million
≈ $490.17 Million
--
pp = percentage points

About Canopy Growth Corp

TO:WEED Canada Drug Manufacturers - Specialty & Generic
Market Cap
$394.56 Million
CA$545.44 Million CAD
Market Cap Rank
#13314 Global
#395 in Canada
Share Price
CA$1.29
Change (1 day)
+0.78%
52-Week Range
CA$1.20 - CA$2.65
All Time High
CA$737.50
About

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such… Read more